nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—CYP2C8—Raloxifene—osteoporosis	0.0538	0.0992	CbGbCtD
Lapatinib—CYP2C8—Ethinyl Estradiol—osteoporosis	0.052	0.0958	CbGbCtD
Lapatinib—CYP2C8—Cholecalciferol—osteoporosis	0.0416	0.0766	CbGbCtD
Lapatinib—ABCB1—Ethinyl Estradiol—osteoporosis	0.0352	0.0648	CbGbCtD
Lapatinib—CYP2C19—Cholecalciferol—osteoporosis	0.0349	0.0642	CbGbCtD
Lapatinib—CYP3A5—Estradiol—osteoporosis	0.0348	0.0642	CbGbCtD
Lapatinib—CYP2C8—Estradiol—osteoporosis	0.0335	0.0617	CbGbCtD
Lapatinib—CYP3A4—Estropipate—osteoporosis	0.0327	0.0603	CbGbCtD
Lapatinib—CYP3A4—Calcitriol—osteoporosis	0.0327	0.0603	CbGbCtD
Lapatinib—CYP2C19—Estradiol—osteoporosis	0.0281	0.0518	CbGbCtD
Lapatinib—CYP3A4—Ergocalciferol—osteoporosis	0.0262	0.0482	CbGbCtD
Lapatinib—ABCB1—Conjugated Estrogens—osteoporosis	0.0258	0.0476	CbGbCtD
Lapatinib—ABCB1—Estradiol—osteoporosis	0.0227	0.0418	CbGbCtD
Lapatinib—CYP3A4—Raloxifene—osteoporosis	0.0218	0.0402	CbGbCtD
Lapatinib—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0211	0.0388	CbGbCtD
Lapatinib—CYP3A4—Cholecalciferol—osteoporosis	0.0169	0.0311	CbGbCtD
Lapatinib—CYP3A4—Conjugated Estrogens—osteoporosis	0.0155	0.0285	CbGbCtD
Lapatinib—CYP3A4—Estradiol—osteoporosis	0.0136	0.025	CbGbCtD
Lapatinib—PIK3C2B—Exemestane—Estropipate—osteoporosis	0.0017	0.224	CbGdCrCtD
Lapatinib—ERBB2—Exemestane—Estropipate—osteoporosis	0.0014	0.184	CbGdCrCtD
Lapatinib—PIK3C2B—Exemestane—Conjugated Estrogens—osteoporosis	0.00129	0.169	CbGdCrCtD
Lapatinib—ERBB2—Exemestane—Conjugated Estrogens—osteoporosis	0.00106	0.139	CbGdCrCtD
Lapatinib—PIK3C2B—Levorphanol—Estradiol—osteoporosis	0.000692	0.0909	CbGdCrCtD
Lapatinib—Cough—Risedronate—osteoporosis	0.0005	0.00208	CcSEcCtD
Lapatinib—Dyspepsia—Ibandronate—osteoporosis	0.000499	0.00207	CcSEcCtD
Lapatinib—Angiopathy—Conjugated Estrogens—osteoporosis	0.000499	0.00207	CcSEcCtD
Lapatinib—Constipation—Alendronate—osteoporosis	0.000498	0.00207	CcSEcCtD
Lapatinib—Malnutrition—Zoledronate—osteoporosis	0.000497	0.00207	CcSEcCtD
Lapatinib—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000497	0.00206	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000497	0.00206	CcSEcCtD
Lapatinib—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000496	0.00206	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000495	0.00205	CcSEcCtD
Lapatinib—Pneumonia—Estradiol—osteoporosis	0.000493	0.00205	CcSEcCtD
Lapatinib—Decreased appetite—Ibandronate—osteoporosis	0.000493	0.00205	CcSEcCtD
Lapatinib—Infestation—Estradiol—osteoporosis	0.00049	0.00204	CcSEcCtD
Lapatinib—Infestation NOS—Estradiol—osteoporosis	0.00049	0.00204	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00049	0.00203	CcSEcCtD
Lapatinib—Fatigue—Ibandronate—osteoporosis	0.000489	0.00203	CcSEcCtD
Lapatinib—Myalgia—Risedronate—osteoporosis	0.000488	0.00202	CcSEcCtD
Lapatinib—Arthralgia—Risedronate—osteoporosis	0.000488	0.00202	CcSEcCtD
Lapatinib—Leukopenia—Pamidronate—osteoporosis	0.000487	0.00202	CcSEcCtD
Lapatinib—Alopecia—Conjugated Estrogens—osteoporosis	0.000486	0.00202	CcSEcCtD
Lapatinib—Constipation—Ibandronate—osteoporosis	0.000485	0.00201	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000484	0.00201	CcSEcCtD
Lapatinib—Pruritus—Etidronic acid—osteoporosis	0.000484	0.00201	CcSEcCtD
Lapatinib—Gastrointestinal pain—Estropipate—osteoporosis	0.000484	0.00201	CcSEcCtD
Lapatinib—Decreased appetite—Calcitriol—osteoporosis	0.000483	0.002	CcSEcCtD
Lapatinib—Mental disorder—Conjugated Estrogens—osteoporosis	0.000482	0.002	CcSEcCtD
Lapatinib—Back pain—Zoledronate—osteoporosis	0.000481	0.002	CcSEcCtD
Lapatinib—Neuropathy peripheral—Estradiol—osteoporosis	0.000481	0.002	CcSEcCtD
Lapatinib—Malnutrition—Conjugated Estrogens—osteoporosis	0.000479	0.00199	CcSEcCtD
Lapatinib—Gastrointestinal pain—Alendronate—osteoporosis	0.000476	0.00198	CcSEcCtD
Lapatinib—Infection—Ethinyl Estradiol—osteoporosis	0.000476	0.00198	CcSEcCtD
Lapatinib—Cough—Pamidronate—osteoporosis	0.000475	0.00197	CcSEcCtD
Lapatinib—Constipation—Calcitriol—osteoporosis	0.000475	0.00197	CcSEcCtD
Lapatinib—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00047	0.00195	CcSEcCtD
Lapatinib—Gastrointestinal pain—Raloxifene—osteoporosis	0.000468	0.00195	CcSEcCtD
Lapatinib—Diarrhoea—Etidronic acid—osteoporosis	0.000468	0.00194	CcSEcCtD
Lapatinib—Abdominal pain—Estropipate—osteoporosis	0.000467	0.00194	CcSEcCtD
Lapatinib—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000466	0.00193	CcSEcCtD
Lapatinib—Infection—Risedronate—osteoporosis	0.000464	0.00193	CcSEcCtD
Lapatinib—Hepatobiliary disease—Estradiol—osteoporosis	0.000464	0.00193	CcSEcCtD
Lapatinib—Gastrointestinal pain—Ibandronate—osteoporosis	0.000464	0.00193	CcSEcCtD
Lapatinib—Arthralgia—Pamidronate—osteoporosis	0.000463	0.00192	CcSEcCtD
Lapatinib—Myalgia—Pamidronate—osteoporosis	0.000463	0.00192	CcSEcCtD
Lapatinib—Back pain—Conjugated Estrogens—osteoporosis	0.000463	0.00192	CcSEcCtD
Lapatinib—Epistaxis—Estradiol—osteoporosis	0.000463	0.00192	CcSEcCtD
Lapatinib—Abdominal pain—Alendronate—osteoporosis	0.00046	0.00191	CcSEcCtD
Lapatinib—Anaemia—Zoledronate—osteoporosis	0.00046	0.00191	CcSEcCtD
Lapatinib—Nervous system disorder—Risedronate—osteoporosis	0.000458	0.0019	CcSEcCtD
Lapatinib—PIK3C2B—Danazol—Ethinyl Estradiol—osteoporosis	0.000457	0.06	CbGdCrCtD
Lapatinib—Skin disorder—Risedronate—osteoporosis	0.000454	0.00189	CcSEcCtD
Lapatinib—Gastrointestinal pain—Calcitriol—osteoporosis	0.000454	0.00189	CcSEcCtD
Lapatinib—Abdominal pain—Raloxifene—osteoporosis	0.000453	0.00188	CcSEcCtD
Lapatinib—Abdominal pain—Ibandronate—osteoporosis	0.000448	0.00186	CcSEcCtD
Lapatinib—Leukopenia—Zoledronate—osteoporosis	0.000445	0.00185	CcSEcCtD
Lapatinib—Anaphylactic shock—Pamidronate—osteoporosis	0.000444	0.00185	CcSEcCtD
Lapatinib—Infection—Pamidronate—osteoporosis	0.000441	0.00183	CcSEcCtD
Lapatinib—Palpitations—Zoledronate—osteoporosis	0.000439	0.00182	CcSEcCtD
Lapatinib—Abdominal pain—Calcitriol—osteoporosis	0.000439	0.00182	CcSEcCtD
Lapatinib—Hypersensitivity—Estropipate—osteoporosis	0.000436	0.00181	CcSEcCtD
Lapatinib—Nervous system disorder—Pamidronate—osteoporosis	0.000436	0.00181	CcSEcCtD
Lapatinib—Vomiting—Etidronic acid—osteoporosis	0.000435	0.0018	CcSEcCtD
Lapatinib—Cough—Zoledronate—osteoporosis	0.000434	0.0018	CcSEcCtD
Lapatinib—Connective tissue disorder—Estradiol—osteoporosis	0.000433	0.0018	CcSEcCtD
Lapatinib—Rash—Etidronic acid—osteoporosis	0.000431	0.00179	CcSEcCtD
Lapatinib—Dermatitis—Etidronic acid—osteoporosis	0.000431	0.00179	CcSEcCtD
Lapatinib—Hypersensitivity—Alendronate—osteoporosis	0.000429	0.00178	CcSEcCtD
Lapatinib—Headache—Etidronic acid—osteoporosis	0.000428	0.00178	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000426	0.00177	CcSEcCtD
Lapatinib—Asthenia—Estropipate—osteoporosis	0.000424	0.00176	CcSEcCtD
Lapatinib—Anorexia—Pamidronate—osteoporosis	0.000423	0.00176	CcSEcCtD
Lapatinib—Myalgia—Zoledronate—osteoporosis	0.000423	0.00176	CcSEcCtD
Lapatinib—Arthralgia—Zoledronate—osteoporosis	0.000423	0.00176	CcSEcCtD
Lapatinib—Palpitations—Conjugated Estrogens—osteoporosis	0.000423	0.00176	CcSEcCtD
Lapatinib—Insomnia—Risedronate—osteoporosis	0.000423	0.00176	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00042	0.00175	CcSEcCtD
Lapatinib—Pruritus—Estropipate—osteoporosis	0.000418	0.00174	CcSEcCtD
Lapatinib—Asthenia—Alendronate—osteoporosis	0.000418	0.00174	CcSEcCtD
Lapatinib—Hypersensitivity—Ibandronate—osteoporosis	0.000418	0.00174	CcSEcCtD
Lapatinib—Cough—Conjugated Estrogens—osteoporosis	0.000418	0.00174	CcSEcCtD
Lapatinib—Dyspnoea—Risedronate—osteoporosis	0.000417	0.00173	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000414	0.00172	CcSEcCtD
Lapatinib—Fatigue—Ethinyl Estradiol—osteoporosis	0.000413	0.00172	CcSEcCtD
Lapatinib—Pruritus—Alendronate—osteoporosis	0.000412	0.00171	CcSEcCtD
Lapatinib—PIK3C2B—Norethindrone—Ethinyl Estradiol—osteoporosis	0.000412	0.0541	CbGdCrCtD
Lapatinib—Dyspepsia—Risedronate—osteoporosis	0.000411	0.00171	CcSEcCtD
Lapatinib—Constipation—Ethinyl Estradiol—osteoporosis	0.00041	0.0017	CcSEcCtD
Lapatinib—Hypersensitivity—Calcitriol—osteoporosis	0.000409	0.0017	CcSEcCtD
Lapatinib—Cardiac disorder—Estradiol—osteoporosis	0.000409	0.0017	CcSEcCtD
Lapatinib—Myalgia—Conjugated Estrogens—osteoporosis	0.000408	0.00169	CcSEcCtD
Lapatinib—Arthralgia—Conjugated Estrogens—osteoporosis	0.000408	0.00169	CcSEcCtD
Lapatinib—Asthenia—Ibandronate—osteoporosis	0.000407	0.00169	CcSEcCtD
Lapatinib—Nausea—Etidronic acid—osteoporosis	0.000406	0.00169	CcSEcCtD
Lapatinib—Anaphylactic shock—Zoledronate—osteoporosis	0.000406	0.00169	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000405	0.00168	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000405	0.00168	CcSEcCtD
Lapatinib—Diarrhoea—Estropipate—osteoporosis	0.000405	0.00168	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Risedronate—osteoporosis	0.000403	0.00168	CcSEcCtD
Lapatinib—Infection—Zoledronate—osteoporosis	0.000403	0.00167	CcSEcCtD
Lapatinib—Fatigue—Risedronate—osteoporosis	0.000403	0.00167	CcSEcCtD
Lapatinib—Insomnia—Pamidronate—osteoporosis	0.000402	0.00167	CcSEcCtD
Lapatinib—Pruritus—Ibandronate—osteoporosis	0.000401	0.00167	CcSEcCtD
Lapatinib—Constipation—Risedronate—osteoporosis	0.0004	0.00166	CcSEcCtD
Lapatinib—Angiopathy—Estradiol—osteoporosis	0.000399	0.00166	CcSEcCtD
Lapatinib—Diarrhoea—Alendronate—osteoporosis	0.000399	0.00166	CcSEcCtD
Lapatinib—Asthenia—Calcitriol—osteoporosis	0.000398	0.00165	CcSEcCtD
Lapatinib—Nervous system disorder—Zoledronate—osteoporosis	0.000398	0.00165	CcSEcCtD
Lapatinib—Immune system disorder—Estradiol—osteoporosis	0.000398	0.00165	CcSEcCtD
Lapatinib—Mediastinal disorder—Estradiol—osteoporosis	0.000397	0.00165	CcSEcCtD
Lapatinib—Dyspnoea—Pamidronate—osteoporosis	0.000396	0.00164	CcSEcCtD
Lapatinib—Skin disorder—Zoledronate—osteoporosis	0.000394	0.00164	CcSEcCtD
Lapatinib—Pruritus—Calcitriol—osteoporosis	0.000393	0.00163	CcSEcCtD
Lapatinib—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000392	0.00163	CcSEcCtD
Lapatinib—Diarrhoea—Raloxifene—osteoporosis	0.000392	0.00163	CcSEcCtD
Lapatinib—Dyspepsia—Pamidronate—osteoporosis	0.000391	0.00162	CcSEcCtD
Lapatinib—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000391	0.00162	CcSEcCtD
Lapatinib—Alopecia—Estradiol—osteoporosis	0.000389	0.00162	CcSEcCtD
Lapatinib—Infection—Conjugated Estrogens—osteoporosis	0.000388	0.00161	CcSEcCtD
Lapatinib—Diarrhoea—Ibandronate—osteoporosis	0.000388	0.00161	CcSEcCtD
Lapatinib—Anorexia—Zoledronate—osteoporosis	0.000387	0.00161	CcSEcCtD
Lapatinib—Decreased appetite—Pamidronate—osteoporosis	0.000386	0.0016	CcSEcCtD
Lapatinib—Mental disorder—Estradiol—osteoporosis	0.000386	0.0016	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000384	0.00159	CcSEcCtD
Lapatinib—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000383	0.00159	CcSEcCtD
Lapatinib—Malnutrition—Estradiol—osteoporosis	0.000383	0.00159	CcSEcCtD
Lapatinib—Fatigue—Pamidronate—osteoporosis	0.000383	0.00159	CcSEcCtD
Lapatinib—Gastrointestinal pain—Risedronate—osteoporosis	0.000382	0.00159	CcSEcCtD
Lapatinib—Constipation—Pamidronate—osteoporosis	0.00038	0.00158	CcSEcCtD
Lapatinib—Diarrhoea—Calcitriol—osteoporosis	0.00038	0.00158	CcSEcCtD
Lapatinib—Skin disorder—Conjugated Estrogens—osteoporosis	0.00038	0.00158	CcSEcCtD
Lapatinib—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000379	0.00157	CcSEcCtD
Lapatinib—Vomiting—Estropipate—osteoporosis	0.000376	0.00156	CcSEcCtD
Lapatinib—Rash—Estropipate—osteoporosis	0.000373	0.00155	CcSEcCtD
Lapatinib—Dermatitis—Estropipate—osteoporosis	0.000373	0.00155	CcSEcCtD
Lapatinib—Anorexia—Conjugated Estrogens—osteoporosis	0.000372	0.00155	CcSEcCtD
Lapatinib—Back pain—Estradiol—osteoporosis	0.000371	0.00154	CcSEcCtD
Lapatinib—Headache—Estropipate—osteoporosis	0.00037	0.00154	CcSEcCtD
Lapatinib—Vomiting—Alendronate—osteoporosis	0.00037	0.00154	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00037	0.00154	CcSEcCtD
Lapatinib—Abdominal pain—Risedronate—osteoporosis	0.000369	0.00153	CcSEcCtD
Lapatinib—Rash—Alendronate—osteoporosis	0.000367	0.00153	CcSEcCtD
Lapatinib—Insomnia—Zoledronate—osteoporosis	0.000367	0.00152	CcSEcCtD
Lapatinib—Dermatitis—Alendronate—osteoporosis	0.000367	0.00152	CcSEcCtD
Lapatinib—Headache—Alendronate—osteoporosis	0.000365	0.00152	CcSEcCtD
Lapatinib—Vomiting—Raloxifene—osteoporosis	0.000364	0.00151	CcSEcCtD
Lapatinib—Gastrointestinal pain—Pamidronate—osteoporosis	0.000363	0.00151	CcSEcCtD
Lapatinib—Dyspnoea—Zoledronate—osteoporosis	0.000362	0.0015	CcSEcCtD
Lapatinib—Rash—Raloxifene—osteoporosis	0.000361	0.0015	CcSEcCtD
Lapatinib—Dermatitis—Raloxifene—osteoporosis	0.000361	0.0015	CcSEcCtD
Lapatinib—Vomiting—Ibandronate—osteoporosis	0.000361	0.0015	CcSEcCtD
Lapatinib—Headache—Raloxifene—osteoporosis	0.000359	0.00149	CcSEcCtD
Lapatinib—Rash—Ibandronate—osteoporosis	0.000358	0.00148	CcSEcCtD
Lapatinib—Dermatitis—Ibandronate—osteoporosis	0.000357	0.00148	CcSEcCtD
Lapatinib—Dyspepsia—Zoledronate—osteoporosis	0.000357	0.00148	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000356	0.00148	CcSEcCtD
Lapatinib—Headache—Ibandronate—osteoporosis	0.000355	0.00148	CcSEcCtD
Lapatinib—Insomnia—Conjugated Estrogens—osteoporosis	0.000353	0.00147	CcSEcCtD
Lapatinib—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000353	0.00147	CcSEcCtD
Lapatinib—Vomiting—Calcitriol—osteoporosis	0.000353	0.00147	CcSEcCtD
Lapatinib—Decreased appetite—Zoledronate—osteoporosis	0.000353	0.00147	CcSEcCtD
Lapatinib—Nausea—Estropipate—osteoporosis	0.000351	0.00146	CcSEcCtD
Lapatinib—Abdominal pain—Pamidronate—osteoporosis	0.000351	0.00146	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00035	0.00146	CcSEcCtD
Lapatinib—Rash—Calcitriol—osteoporosis	0.00035	0.00145	CcSEcCtD
Lapatinib—Fatigue—Zoledronate—osteoporosis	0.00035	0.00145	CcSEcCtD
Lapatinib—Dermatitis—Calcitriol—osteoporosis	0.00035	0.00145	CcSEcCtD
Lapatinib—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000348	0.00145	CcSEcCtD
Lapatinib—Headache—Calcitriol—osteoporosis	0.000348	0.00144	CcSEcCtD
Lapatinib—Constipation—Zoledronate—osteoporosis	0.000347	0.00144	CcSEcCtD
Lapatinib—Nausea—Alendronate—osteoporosis	0.000346	0.00144	CcSEcCtD
Lapatinib—Hypersensitivity—Risedronate—osteoporosis	0.000344	0.00143	CcSEcCtD
Lapatinib—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000344	0.00143	CcSEcCtD
Lapatinib—Asthenia—Ethinyl Estradiol—osteoporosis	0.000344	0.00143	CcSEcCtD
Lapatinib—Nausea—Raloxifene—osteoporosis	0.00034	0.00141	CcSEcCtD
Lapatinib—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00034	0.00141	CcSEcCtD
Lapatinib—Pruritus—Ethinyl Estradiol—osteoporosis	0.000339	0.00141	CcSEcCtD
Lapatinib—Palpitations—Estradiol—osteoporosis	0.000339	0.00141	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000337	0.0014	CcSEcCtD
Lapatinib—Fatigue—Conjugated Estrogens—osteoporosis	0.000337	0.0014	CcSEcCtD
Lapatinib—Nausea—Ibandronate—osteoporosis	0.000337	0.0014	CcSEcCtD
Lapatinib—Asthenia—Risedronate—osteoporosis	0.000335	0.00139	CcSEcCtD
Lapatinib—Cough—Estradiol—osteoporosis	0.000334	0.00139	CcSEcCtD
Lapatinib—Constipation—Conjugated Estrogens—osteoporosis	0.000334	0.00139	CcSEcCtD
Lapatinib—Gastrointestinal pain—Zoledronate—osteoporosis	0.000332	0.00138	CcSEcCtD
Lapatinib—Pruritus—Risedronate—osteoporosis	0.000331	0.00137	CcSEcCtD
Lapatinib—Nausea—Calcitriol—osteoporosis	0.00033	0.00137	CcSEcCtD
Lapatinib—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000328	0.00136	CcSEcCtD
Lapatinib—PIK3C2B—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000328	0.043	CbGdCrCtD
Lapatinib—Hypersensitivity—Pamidronate—osteoporosis	0.000327	0.00136	CcSEcCtD
Lapatinib—Arthralgia—Estradiol—osteoporosis	0.000326	0.00135	CcSEcCtD
Lapatinib—Myalgia—Estradiol—osteoporosis	0.000326	0.00135	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000324	0.00135	CcSEcCtD
Lapatinib—Abdominal pain—Zoledronate—osteoporosis	0.000321	0.00133	CcSEcCtD
Lapatinib—Diarrhoea—Risedronate—osteoporosis	0.00032	0.00133	CcSEcCtD
Lapatinib—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00032	0.00133	CcSEcCtD
Lapatinib—Asthenia—Pamidronate—osteoporosis	0.000319	0.00132	CcSEcCtD
Lapatinib—Pruritus—Pamidronate—osteoporosis	0.000314	0.00131	CcSEcCtD
Lapatinib—Anaphylactic shock—Estradiol—osteoporosis	0.000313	0.0013	CcSEcCtD
Lapatinib—Infection—Estradiol—osteoporosis	0.000311	0.00129	CcSEcCtD
Lapatinib—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000309	0.00128	CcSEcCtD
Lapatinib—Nervous system disorder—Estradiol—osteoporosis	0.000307	0.00127	CcSEcCtD
Lapatinib—Vomiting—Ethinyl Estradiol—osteoporosis	0.000305	0.00127	CcSEcCtD
Lapatinib—Diarrhoea—Pamidronate—osteoporosis	0.000304	0.00126	CcSEcCtD
Lapatinib—Skin disorder—Estradiol—osteoporosis	0.000304	0.00126	CcSEcCtD
Lapatinib—Rash—Ethinyl Estradiol—osteoporosis	0.000302	0.00126	CcSEcCtD
Lapatinib—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000302	0.00125	CcSEcCtD
Lapatinib—Headache—Ethinyl Estradiol—osteoporosis	0.0003	0.00125	CcSEcCtD
Lapatinib—Hypersensitivity—Zoledronate—osteoporosis	0.000299	0.00124	CcSEcCtD
Lapatinib—Vomiting—Risedronate—osteoporosis	0.000297	0.00123	CcSEcCtD
Lapatinib—Rash—Risedronate—osteoporosis	0.000295	0.00122	CcSEcCtD
Lapatinib—Dermatitis—Risedronate—osteoporosis	0.000294	0.00122	CcSEcCtD
Lapatinib—Headache—Risedronate—osteoporosis	0.000293	0.00122	CcSEcCtD
Lapatinib—Asthenia—Zoledronate—osteoporosis	0.000291	0.00121	CcSEcCtD
Lapatinib—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000288	0.0012	CcSEcCtD
Lapatinib—Pruritus—Zoledronate—osteoporosis	0.000287	0.00119	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000285	0.00118	CcSEcCtD
Lapatinib—Nausea—Ethinyl Estradiol—osteoporosis	0.000285	0.00118	CcSEcCtD
Lapatinib—Insomnia—Estradiol—osteoporosis	0.000283	0.00117	CcSEcCtD
Lapatinib—Vomiting—Pamidronate—osteoporosis	0.000282	0.00117	CcSEcCtD
Lapatinib—Asthenia—Conjugated Estrogens—osteoporosis	0.00028	0.00116	CcSEcCtD
Lapatinib—Rash—Pamidronate—osteoporosis	0.00028	0.00116	CcSEcCtD
Lapatinib—Dermatitis—Pamidronate—osteoporosis	0.00028	0.00116	CcSEcCtD
Lapatinib—Dyspnoea—Estradiol—osteoporosis	0.000279	0.00116	CcSEcCtD
Lapatinib—Headache—Pamidronate—osteoporosis	0.000278	0.00116	CcSEcCtD
Lapatinib—Diarrhoea—Zoledronate—osteoporosis	0.000278	0.00115	CcSEcCtD
Lapatinib—Nausea—Risedronate—osteoporosis	0.000278	0.00115	CcSEcCtD
Lapatinib—Pruritus—Conjugated Estrogens—osteoporosis	0.000276	0.00115	CcSEcCtD
Lapatinib—Dyspepsia—Estradiol—osteoporosis	0.000275	0.00114	CcSEcCtD
Lapatinib—Decreased appetite—Estradiol—osteoporosis	0.000272	0.00113	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Estradiol—osteoporosis	0.00027	0.00112	CcSEcCtD
Lapatinib—ERBB2—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00027	0.0354	CbGdCrCtD
Lapatinib—Fatigue—Estradiol—osteoporosis	0.00027	0.00112	CcSEcCtD
Lapatinib—Constipation—Estradiol—osteoporosis	0.000267	0.00111	CcSEcCtD
Lapatinib—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000267	0.00111	CcSEcCtD
Lapatinib—Nausea—Pamidronate—osteoporosis	0.000264	0.0011	CcSEcCtD
Lapatinib—Vomiting—Zoledronate—osteoporosis	0.000258	0.00107	CcSEcCtD
Lapatinib—Rash—Zoledronate—osteoporosis	0.000256	0.00106	CcSEcCtD
Lapatinib—Gastrointestinal pain—Estradiol—osteoporosis	0.000256	0.00106	CcSEcCtD
Lapatinib—Dermatitis—Zoledronate—osteoporosis	0.000256	0.00106	CcSEcCtD
Lapatinib—Headache—Zoledronate—osteoporosis	0.000254	0.00106	CcSEcCtD
Lapatinib—Vomiting—Conjugated Estrogens—osteoporosis	0.000248	0.00103	CcSEcCtD
Lapatinib—Abdominal pain—Estradiol—osteoporosis	0.000247	0.00103	CcSEcCtD
Lapatinib—Rash—Conjugated Estrogens—osteoporosis	0.000246	0.00102	CcSEcCtD
Lapatinib—Dermatitis—Conjugated Estrogens—osteoporosis	0.000246	0.00102	CcSEcCtD
Lapatinib—Headache—Conjugated Estrogens—osteoporosis	0.000245	0.00102	CcSEcCtD
Lapatinib—Nausea—Zoledronate—osteoporosis	0.000241	0.001	CcSEcCtD
Lapatinib—Nausea—Conjugated Estrogens—osteoporosis	0.000232	0.000964	CcSEcCtD
Lapatinib—Hypersensitivity—Estradiol—osteoporosis	0.00023	0.000957	CcSEcCtD
Lapatinib—Asthenia—Estradiol—osteoporosis	0.000224	0.000932	CcSEcCtD
Lapatinib—Pruritus—Estradiol—osteoporosis	0.000221	0.000919	CcSEcCtD
Lapatinib—Diarrhoea—Estradiol—osteoporosis	0.000214	0.000889	CcSEcCtD
Lapatinib—Vomiting—Estradiol—osteoporosis	0.000199	0.000826	CcSEcCtD
Lapatinib—Rash—Estradiol—osteoporosis	0.000197	0.000819	CcSEcCtD
Lapatinib—Dermatitis—Estradiol—osteoporosis	0.000197	0.000818	CcSEcCtD
Lapatinib—Headache—Estradiol—osteoporosis	0.000196	0.000814	CcSEcCtD
Lapatinib—Nausea—Estradiol—osteoporosis	0.000186	0.000771	CcSEcCtD
Lapatinib—CYP2C19—Metabolism—FDPS—osteoporosis	3.93e-05	0.000188	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—IL6—osteoporosis	3.92e-05	0.000188	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—IL6—osteoporosis	3.86e-05	0.000185	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TNF—osteoporosis	3.85e-05	0.000185	CbGpPWpGaD
Lapatinib—EGFR—Disease—FGA—osteoporosis	3.84e-05	0.000184	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PKM—osteoporosis	3.83e-05	0.000184	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—FDPS—osteoporosis	3.83e-05	0.000184	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IRS1—osteoporosis	3.82e-05	0.000183	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PNP—osteoporosis	3.81e-05	0.000183	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ATIC—osteoporosis	3.81e-05	0.000183	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IRS1—osteoporosis	3.77e-05	0.00018	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—OXCT1—osteoporosis	3.74e-05	0.000179	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CA2—osteoporosis	3.74e-05	0.000179	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CALCA—osteoporosis	3.72e-05	0.000178	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GPD2—osteoporosis	3.72e-05	0.000178	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PGLS—osteoporosis	3.72e-05	0.000178	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—IL6—osteoporosis	3.69e-05	0.000177	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—IL6—osteoporosis	3.67e-05	0.000176	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—IL6—osteoporosis	3.65e-05	0.000175	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PSMA2—osteoporosis	3.65e-05	0.000175	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PSMA5—osteoporosis	3.65e-05	0.000175	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—MGLL—osteoporosis	3.65e-05	0.000175	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IRS2—osteoporosis	3.64e-05	0.000174	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—IL6—osteoporosis	3.63e-05	0.000174	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PGLS—osteoporosis	3.63e-05	0.000174	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GPD2—osteoporosis	3.63e-05	0.000174	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TLN1—osteoporosis	3.59e-05	0.000172	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.59e-05	0.000172	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL6R—osteoporosis	3.59e-05	0.000172	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL6R—osteoporosis	3.54e-05	0.00017	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IRS1—osteoporosis	3.53e-05	0.000169	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—IRS2—osteoporosis	3.49e-05	0.000167	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IRS1—osteoporosis	3.48e-05	0.000167	CbGpPWpGaD
Lapatinib—EGFR—Disease—ENO1—osteoporosis	3.42e-05	0.000164	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—IL6—osteoporosis	3.42e-05	0.000164	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—IL6—osteoporosis	3.42e-05	0.000164	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—osteoporosis	3.42e-05	0.000164	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ATIC—osteoporosis	3.4e-05	0.000163	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PNP—osteoporosis	3.4e-05	0.000163	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—IL6—osteoporosis	3.39e-05	0.000162	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—IL6R—osteoporosis	3.38e-05	0.000162	CbGpPWpGaD
Lapatinib—EGFR—Disease—PSMA5—osteoporosis	3.37e-05	0.000161	CbGpPWpGaD
Lapatinib—EGFR—Disease—PSMA2—osteoporosis	3.37e-05	0.000161	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—IL6—osteoporosis	3.36e-05	0.000161	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—IL6—osteoporosis	3.34e-05	0.00016	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PNP—osteoporosis	3.32e-05	0.000159	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ATIC—osteoporosis	3.32e-05	0.000159	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IL6R—osteoporosis	3.32e-05	0.000159	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IL6R—osteoporosis	3.27e-05	0.000157	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—OXCT1—osteoporosis	3.24e-05	0.000155	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CA2—osteoporosis	3.24e-05	0.000155	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—ADCY5—osteoporosis	3.24e-05	0.000155	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ADCY5—osteoporosis	3.19e-05	0.000153	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IRS1—osteoporosis	3.17e-05	0.000152	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MGLL—osteoporosis	3.16e-05	0.000151	CbGpPWpGaD
Lapatinib—EGFR—Disease—CALCA—osteoporosis	3.14e-05	0.000151	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SPP1—osteoporosis	3.13e-05	0.00015	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—IL6—osteoporosis	3.11e-05	0.000149	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—IDH2—osteoporosis	3.1e-05	0.000149	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—P4HB—osteoporosis	3.1e-05	0.000149	CbGpPWpGaD
Lapatinib—EGFR—Immune System—KL—osteoporosis	3.09e-05	0.000148	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SPP1—osteoporosis	3.08e-05	0.000148	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—IRS1—osteoporosis	3.05e-05	0.000146	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	3.03e-05	0.000145	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PTH—osteoporosis	3.02e-05	0.000144	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IL6R—osteoporosis	2.98e-05	0.000143	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.98e-05	0.000143	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RAP1A—osteoporosis	2.96e-05	0.000142	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CNR2—osteoporosis	2.94e-05	0.000141	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.93e-05	0.00014	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CYP27A1—osteoporosis	2.92e-05	0.00014	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CA2—osteoporosis	2.89e-05	0.000139	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—OXCT1—osteoporosis	2.89e-05	0.000139	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NFATC1—osteoporosis	2.89e-05	0.000139	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—DKK1—osteoporosis	2.87e-05	0.000137	CbGpPWpGaD
Lapatinib—EGFR—Disease—KL—osteoporosis	2.85e-05	0.000137	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ACP5—osteoporosis	2.84e-05	0.000136	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IRS2—osteoporosis	2.83e-05	0.000136	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—OXCT1—osteoporosis	2.82e-05	0.000135	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CA2—osteoporosis	2.82e-05	0.000135	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MGLL—osteoporosis	2.82e-05	0.000135	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IRS2—osteoporosis	2.79e-05	0.000134	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—LEP—osteoporosis	2.77e-05	0.000133	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—WNT1—osteoporosis	2.76e-05	0.000132	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MGLL—osteoporosis	2.75e-05	0.000132	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—IL6—osteoporosis	2.75e-05	0.000132	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL1B—osteoporosis	2.73e-05	0.000131	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—LEP—osteoporosis	2.73e-05	0.000131	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—IL6—osteoporosis	2.71e-05	0.00013	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL1B—osteoporosis	2.69e-05	0.000129	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FGA—osteoporosis	2.69e-05	0.000129	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—IDH2—osteoporosis	2.69e-05	0.000129	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.66e-05	0.000127	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—ADCY5—osteoporosis	2.65e-05	0.000127	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—ESR1—osteoporosis	2.65e-05	0.000127	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—TPI1—osteoporosis	2.64e-05	0.000126	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ESR1—osteoporosis	2.61e-05	0.000125	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP27A1—osteoporosis	2.53e-05	0.000121	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—POMC—osteoporosis	2.5e-05	0.00012	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—BMP2—osteoporosis	2.5e-05	0.00012	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PTHLH—osteoporosis	2.5e-05	0.00012	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—P4HB—osteoporosis	2.48e-05	0.000119	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IRS1—osteoporosis	2.47e-05	0.000118	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ACP5—osteoporosis	2.46e-05	0.000118	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FGB—osteoporosis	2.44e-05	0.000117	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IRS1—osteoporosis	2.44e-05	0.000117	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GAPDH—osteoporosis	2.43e-05	0.000117	CbGpPWpGaD
Lapatinib—EGFR—Immune System—AGER—osteoporosis	2.43e-05	0.000116	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.43e-05	0.000116	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ADCY5—osteoporosis	2.42e-05	0.000116	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—IDH2—osteoporosis	2.4e-05	0.000115	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—POMC—osteoporosis	2.38e-05	0.000114	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—RAP1A—osteoporosis	2.37e-05	0.000114	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PKM—osteoporosis	2.36e-05	0.000113	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—FDPS—osteoporosis	2.36e-05	0.000113	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PSMA2—osteoporosis	2.36e-05	0.000113	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PSMA5—osteoporosis	2.36e-05	0.000113	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—POMC—osteoporosis	2.34e-05	0.000112	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—IDH2—osteoporosis	2.34e-05	0.000112	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—IL6—osteoporosis	2.33e-05	0.000112	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6R—osteoporosis	2.32e-05	0.000111	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IGF1—osteoporosis	2.29e-05	0.00011	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6R—osteoporosis	2.29e-05	0.00011	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—TPI1—osteoporosis	2.28e-05	0.000109	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IGF1—osteoporosis	2.26e-05	0.000108	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.25e-05	0.000108	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GPD2—osteoporosis	2.24e-05	0.000107	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PGLS—osteoporosis	2.24e-05	0.000107	CbGpPWpGaD
Lapatinib—EGFR—Disease—ADCY5—osteoporosis	2.23e-05	0.000107	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP27A1—osteoporosis	2.2e-05	0.000105	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CALCA—osteoporosis	2.2e-05	0.000105	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ACP5—osteoporosis	2.19e-05	0.000105	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.17e-05	0.000104	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.16e-05	0.000103	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.15e-05	0.000103	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—P4HB—osteoporosis	2.15e-05	0.000103	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ACP5—osteoporosis	2.14e-05	0.000103	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IRS2—osteoporosis	2.12e-05	0.000101	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GAPDH—osteoporosis	2.11e-05	0.000101	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—IL6—osteoporosis	2.11e-05	0.000101	CbGpPWpGaD
Lapatinib—EGFR—Disease—MTHFR—osteoporosis	2.05e-05	9.85e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—RAP1A—osteoporosis	2.05e-05	9.84e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ATIC—osteoporosis	2.05e-05	9.81e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PNP—osteoporosis	2.05e-05	9.81e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—TPI1—osteoporosis	2.04e-05	9.77e-05	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.02e-05	9.66e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.01e-05	9.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—KL—osteoporosis	2e-05	9.57e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TGFB1—osteoporosis	2e-05	9.56e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—TPI1—osteoporosis	1.99e-05	9.53e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—MYC—osteoporosis	1.97e-05	9.42e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TGFB1—osteoporosis	1.96e-05	9.39e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IRS2—osteoporosis	1.95e-05	9.37e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—POMC—osteoporosis	1.95e-05	9.33e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—MYC—osteoporosis	1.94e-05	9.27e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TGFB1—osteoporosis	1.93e-05	9.25e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—P4HB—osteoporosis	1.92e-05	9.18e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ENO1—osteoporosis	1.92e-05	9.18e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6R—osteoporosis	1.9e-05	9.11e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PSMA5—osteoporosis	1.89e-05	9.05e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PSMA2—osteoporosis	1.89e-05	9.05e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GAPDH—osteoporosis	1.88e-05	9.02e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—P4HB—osteoporosis	1.87e-05	8.96e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—osteoporosis	1.86e-05	8.93e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IRS1—osteoporosis	1.85e-05	8.86e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GAPDH—osteoporosis	1.84e-05	8.8e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—RAP1A—osteoporosis	1.83e-05	8.78e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.79e-05	8.58e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—RAP1A—osteoporosis	1.79e-05	8.57e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—OXCT1—osteoporosis	1.74e-05	8.34e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CA2—osteoporosis	1.74e-05	8.34e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6R—osteoporosis	1.74e-05	8.32e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IRS1—osteoporosis	1.71e-05	8.18e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MGLL—osteoporosis	1.7e-05	8.13e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ENO1—osteoporosis	1.66e-05	7.95e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PSMA2—osteoporosis	1.64e-05	7.84e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PSMA5—osteoporosis	1.64e-05	7.84e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6R—osteoporosis	1.6e-05	7.68e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL6—osteoporosis	1.6e-05	7.67e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.6e-05	7.66e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL6—osteoporosis	1.58e-05	7.55e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ADCY5—osteoporosis	1.56e-05	7.5e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.53e-05	7.34e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SPP1—osteoporosis	1.51e-05	7.25e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—IL6—osteoporosis	1.5e-05	7.2e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ENO1—osteoporosis	1.48e-05	7.1e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IL6—osteoporosis	1.48e-05	7.08e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PSMA2—osteoporosis	1.46e-05	6.99e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PSMA5—osteoporosis	1.46e-05	6.99e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IL6—osteoporosis	1.46e-05	6.97e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ENO1—osteoporosis	1.45e-05	6.93e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—IDH2—osteoporosis	1.44e-05	6.91e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PSMA2—osteoporosis	1.42e-05	6.83e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PSMA5—osteoporosis	1.42e-05	6.83e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MYC—osteoporosis	1.38e-05	6.59e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TGFB1—osteoporosis	1.37e-05	6.58e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IRS2—osteoporosis	1.37e-05	6.56e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.36e-05	6.5e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MYC—osteoporosis	1.36e-05	6.49e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TGFB1—osteoporosis	1.35e-05	6.48e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—LEP—osteoporosis	1.34e-05	6.42e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IL6—osteoporosis	1.33e-05	6.36e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.33e-05	6.36e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1B—osteoporosis	1.32e-05	6.33e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ACP5—osteoporosis	1.32e-05	6.32e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ESR1—osteoporosis	1.28e-05	6.13e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ADCY5—osteoporosis	1.25e-05	6e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GPX1—osteoporosis	1.25e-05	5.98e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—TPI1—osteoporosis	1.23e-05	5.87e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IRS1—osteoporosis	1.2e-05	5.73e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.18e-05	5.67e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP19A1—osteoporosis	1.16e-05	5.54e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—P4HB—osteoporosis	1.15e-05	5.52e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—MTHFR—osteoporosis	1.15e-05	5.52e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—POMC—osteoporosis	1.15e-05	5.51e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GAPDH—osteoporosis	1.13e-05	5.42e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6R—osteoporosis	1.12e-05	5.38e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IGF1—osteoporosis	1.11e-05	5.3e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—RAP1A—osteoporosis	1.1e-05	5.28e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ADCY5—osteoporosis	1.08e-05	5.19e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GPX1—osteoporosis	1.08e-05	5.18e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6—osteoporosis	1.03e-05	4.96e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6—osteoporosis	1.02e-05	4.88e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MTHFR—osteoporosis	9.97e-06	4.78e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ADCY5—osteoporosis	9.68e-06	4.64e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GPX1—osteoporosis	9.64e-06	4.62e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—MYC—osteoporosis	9.5e-06	4.55e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—TGFB1—osteoporosis	9.48e-06	4.54e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ADCY5—osteoporosis	9.44e-06	4.53e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GPX1—osteoporosis	9.41e-06	4.51e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—POMC—osteoporosis	9.21e-06	4.41e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ENO1—osteoporosis	8.91e-06	4.27e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MTHFR—osteoporosis	8.9e-06	4.26e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PSMA2—osteoporosis	8.78e-06	4.21e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PSMA5—osteoporosis	8.78e-06	4.21e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MTHFR—osteoporosis	8.69e-06	4.16e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6—osteoporosis	8.47e-06	4.06e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—POMC—osteoporosis	7.97e-06	3.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6—osteoporosis	7.73e-06	3.71e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6—osteoporosis	7.14e-06	3.42e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP19A1—osteoporosis	7.12e-06	3.41e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—POMC—osteoporosis	7.12e-06	3.41e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—POMC—osteoporosis	6.95e-06	3.33e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MYC—osteoporosis	6.65e-06	3.19e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TGFB1—osteoporosis	6.64e-06	3.18e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ADCY5—osteoporosis	5.82e-06	2.79e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GPX1—osteoporosis	5.8e-06	2.78e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MTHFR—osteoporosis	5.35e-06	2.56e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6—osteoporosis	5e-06	2.4e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—POMC—osteoporosis	4.28e-06	2.05e-05	CbGpPWpGaD
